Oleoyl-estrone treatment affects the ponderostat setting differently in lean and obese Zucker rats.
OBJECTIVE
To determine whether the slimming effects of treatment with oleoyl-estrone (OE) in liposomes of normal and obese rats are permanent, or disappear as soon as the treatment with the drug ceased. This study was devised to gain further knowledge on the postulated role of OE as a ponderostat signal, evaluating whether (in addition) it can lower the ponderostat setting of the rat.


METHODS
The rats were infused for 14d (using osmotic minipumps) with oleoyl-estrone in liposomes at a dose of 3.5 micromol/kg x d, and were studied up to one month after the treatment ceased.


METHODS
Young adult lean controls (CL) or treated (TL) and obese controls (CO) or treated (TO) Zucker rats.


METHODS
Energy balance, blood glucose, liver glycogen, plasma insulin, leptin corticosterone, ACTH and estrone (free and total) concentrations, and expression of the OB gene in white adipose tissue (WAT).


RESULTS
The loss of body weight caused by OE was recovered quickly in the TO, which gained weight at the same rate as the CO. TL rats, however remained at the low weight attained for one month after the treatment ceased. However, no differences were observed in calculated energy expenditure (EE) between the TL and TC rats once treatment had stopped. In TL and TO rats, liver glycogen concentrations decreased to normal shortly after treatment ceased, and leptin expression and concentrations remained normal and unchanged after the end of OE treatment. In TO rats, plasma glucose, insulin and leptin were lower than in the CO. Total estrone concentrations decreased rapidly in TL rats and more slowly in the TO, and free estrone followed a similar pattern.


CONCLUSIONS
Continuous infusion of liposomes loaded with OE resulted in a decreased energy intake (EI), maintenance of EE and the utilization of body fat reserves in lean and obese rats alike. This process ended in obese rats as soon as the infusion ceased, so that even when the levels of free and total estrone in plasma remained high, there was a marked (and relatively fast) shift toward the basal situation, which translated into an increase in EI, maintenance of estimated EE and a marked buildup of energy stores. In lean rats, the effects of OE on leptin concentrations and OB gene expression persisted after infusion ended.
Adán
C
C
Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Spain.
Cabot
C
C
Vilà
R
R
Grasa
M M
MM
Masanés
R M
RM
Esteve
M
M
Estruch
J
J
Fernández-López
J A
JA
Remesar
X
X
Alemany
M
M
D000324:Adrenocorticotropic Hormone / Q000097:blood; D000818:Animals; D019440:Anti-Obesity Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D002149:Energy Intake; D004734:Energy Metabolism / Q000187:drug effects*; D004970:Estrone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006003:Glycogen / Q000378:metabolism; D007328:Insulin / Q000097:blood; D020738:Leptin; D008081:Liposomes; D008099:Liver / Q000378:metabolism; D009765:Obesity / Q000188:drug therapy* / Q000503:physiopathology; D009829:Oleic Acids / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D011506:Proteins / Q000378:metabolism; D051381:Rats; D011924:Rats, Zucker; D014508:Urea / Q000097:blood
D019440:Anti-Obesity Agents; D001786:Blood Glucose; D007328:Insulin; D020738:Leptin; D008081:Liposomes; D009829:Oleic Acids; D011506:Proteins; D004970:Estrone; C108709:oleoyl-estrone; D014508:Urea; D000324:Adrenocorticotropic Hormone; D006003:Glycogen